Cognex (NASDAQ:CGNX) EVP Sells $90,090.00 in Stock

Key Points

• Cognex EVP Sheila Marie Dipalma sold 2,002 shares of stock for a total of $90,090, representing an 18.92% decrease in her ownership.
• The company's recent earnings report showed $0.25 EPS, exceeding analysts’ expectations of $0.23, with revenue increasing by 4.2% year-over-year.
• Cognex has a current market capitalization of $7.49 billion, with stock analysts giving it a consensus rating of "Moderate Buy".

Cognex Corporation (NASDAQ:CGNX - Get Free Report) EVP Sheila Marie Dipalma sold 2,002 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $45.00, for a total transaction of $90,090.00. Following the completion of the sale, the executive vice president owned 8,582 shares in the company, valued at $386,190. This represents a 18.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Sheila Marie Dipalma also recently made the following trade(s):

• On Monday, September 8th, Sheila Marie Dipalma sold 2,000 shares of Cognex stock. The shares were sold at an average price of $45.03, for a total transaction of $90,060.00.

Cognex Trading Down 1.2%

Shares of CGNX stock traded down $0.56 during trading hours on Friday, hitting $44.39. The company's stock had a trading volume of 1,405,568 shares, compared to its average volume of 1,809,277. The business has a fifty day moving average of $39.81 and a 200-day moving average of $33.04. The stock has a market cap of $7.45 billion, a price-to-earnings ratio of 62.52 and a beta of 1.50. Cognex Corporation has a twelve month low of $22.67 and a twelve month high of $45.23.

Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.23 by $0.02. The business had revenue of $249.09 million for the quarter, compared to analyst estimates of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The company's quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.23 earnings per share. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, equities analysts expect that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were given a $0.08 dividend. The ex-dividend date was Thursday, August 14th. This represents a $0.32 annualized dividend and a dividend yield of 0.7%. Cognex's dividend payout ratio is currently 45.07%.

Hedge Funds Weigh In On Cognex

A number of hedge funds have recently made changes to their positions in CGNX. Jane Street Group LLC raised its stake in shares of Cognex by 8.1% in the 4th quarter. Jane Street Group LLC now owns 75,724 shares of the scientific and technical instruments company's stock valued at $2,715,000 after acquiring an additional 5,696 shares during the period. Ameriprise Financial Inc. raised its stake in shares of Cognex by 62.2% in the 4th quarter. Ameriprise Financial Inc. now owns 1,475,379 shares of the scientific and technical instruments company's stock valued at $52,907,000 after acquiring an additional 566,047 shares during the period. BNP Paribas Financial Markets raised its stake in shares of Cognex by 28.9% in the 4th quarter. BNP Paribas Financial Markets now owns 95,816 shares of the scientific and technical instruments company's stock valued at $3,436,000 after acquiring an additional 21,455 shares during the period. Cetera Investment Advisers raised its stake in shares of Cognex by 15.8% in the 4th quarter. Cetera Investment Advisers now owns 9,018 shares of the scientific and technical instruments company's stock valued at $323,000 after acquiring an additional 1,233 shares during the period. Finally, D. E. Shaw & Co. Inc. purchased a new position in shares of Cognex in the 4th quarter valued at $15,558,000. Hedge funds and other institutional investors own 88.12% of the company's stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. KeyCorp upgraded shares of Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 target price on the stock in a research report on Friday, August 1st. DA Davidson raised their target price on shares of Cognex from $32.00 to $35.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. UBS Group raised their target price on shares of Cognex from $53.00 to $58.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Citigroup restated a "neutral" rating and set a $37.00 target price (up previously from $30.00) on shares of Cognex in a research report on Monday, July 14th. Finally, Robert W. Baird increased their price target on shares of Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a research note on Monday, June 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $42.31.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.